请输入您要查询的百科知识：

　

词条 Causes of Parkinson's disease
释义

  1. Genetic factors

      SNCA gene    LRRK2 gene    GBA gene   Genes underlying familial Parkinson's disease 

  2. Environmental factors

     Pesticides  Metals  Head injuries   Exercise    Caffeine Consumption  

  3. Environmental-Genetic factors

      Polymorphism of CYP2D6 gene and pesticide exposure  

  4. References

{{Too technical|date=January 2014}}

Parkinson's disease (PD) is a degenerative disorder of the central nervous system. Most people with PD have idiopathic Parkinson's disease (having no specific known cause). A small proportion of cases, however, can be attributed to known genetic factors. Other factors such as environmental toxins, herbicides, pesticides, and fungicides, have been associated with the risk of developing PD, but no causal relationships have been proven.

Genetic factors

Traditionally, PD has been considered a non-genetic disorder. However, around 15% of individuals with PD have a first-degree relative who has the disease.[1] At least 5% -15% of cases are known to occur because of a mutation in one of several specific genes, transmitted in either an autosomal-dominant or autosomal-recessive pattern[2]

Mutations in specific genes have been conclusively shown to cause PD. Genes which have been implicated in autosomal-dominant PD include PARK1 and PARK4, PARK5, PARK8, PARK11 and GIGYF2 and PARK13 which code for alpha-synuclein(SNCA), UCHL1, leucine-rich repeat kinase 2 (LRRK2 or dardarin) (LRRK2 and Htra2 respectively[2][3] Genes such as PARK2, PARK6, PARK7 and PARK9 which code for parkin (PRKN), PTEN-induced putative kinase 1 (PINK1), DJ-1 and ATP13A2 respectively have been implicated in the development of autosomal-recessive PD[2][4][5]

Furthermore, mutations in genes including those that code for SNCA, LRRK2 and glucocerebrosidase (GBA) have been found to be risk factors for sporadic PD[6] In most cases, people with these mutations will develop PD. With the exception of LRRK2, however, they account for only a small minority of cases of PD.[7] The most extensively studied PD-related genes are SNCA and LRRK2.

SNCA gene

The role of the SNCA gene is significant in PD because the alpha-synuclein protein is the main component of Lewy bodies, which appear as a primary biomarker in the disease.[2][8] Missense mutations of the gene (in which a single nucleotide is changed), and duplications and triplications of the locus containing it have been found in different groups with familial PD.[2] Level of alpha-synuclein expression correlates with disease onset and progression, with SNCA gene triplication advancing earlier and faster than duplication.[9] Missense mutations in SNCA are rare.[2] On the other hand, multiplications of the SNCA locus account for around 2% of familial cases.[2] Multiplications have been found in asymptomatic carriers, which indicate that penetrance is incomplete or age-dependent.[2]

LRRK2 gene

The LRRK2 gene (PARK8) encodes for a protein called dardarin. The name dardarin was taken from a Basque word for tremor, because this gene was first identified in families from England and the north of Spain.[7] A significant number of autosomal-dominant Parkinson's disease cases are associated with mutations in the LRRK2 gene[10] Mutations in LRRK2 are the most common known cause of familial and sporadic PD, accounting for approximately 5% of individuals with a family history of the disease and 3% of sporadic cases.[2][7] There are many different mutations described in LRRK2, however unequivocal proof of causation only exists for a small number.[2] Mutations in PINK1, PRKN, and DJ-1 may cause mitochondrial dysfunction, an element of both idiopathic and genetic PD.[9] Of related interest are mutations in the progranulin gene that have been found to cause corticobasal degeneration seen in dementia.[11] This could be relevant in PD cases associated with dementia.[11]

GBA gene

Mutations in GBA are known to cause Gaucher's disease.[2] Genome-wide association studies, which search for mutated alleles with low penetrance in sporadic cases, have now yielded many positive results.[12] Mendelian genetics are not strictly observed in GBA mutations found in inherited parkinsonism.[13] Incidentally, both gain-of-function and loss-of-function GBA mutations are proposed to contribute to parkinsonism through effects such as increased alpha-synuclein levels.[13] In patients with Parkinson’s disease, the OR for carrying a GBA mutation was 5·43 (95% CI 3·89–7·57), confirming that mutations in this gene are a common risk factor for Parkinson’s disease.[13]

Genes underlying familial Parkinson's disease

Genes underlying familial PD
HGNC symbol GeneLocus Function Mutations Clinical Presentations Neuropathology Age at onset Inheritance
PARK1/PARK4[14] SNCA[15] (α-synuclein)4q21[16] Unknown synaptic function Duplications Idiopathic PD; some postural tremor; slow progression LBs Mid 20 - 30 Dominant
SNCA4q22[16] instructions for making a small protein called alpha-synuclei [17]

may play a role in maintaining supply of synaptic vesicles in presynaptic terminals;

may regulate release of dopamine [17]

Triplications PD (Parkinson's Disease); PD with dementia;diffuse LBs disease;aggressive course; can develop cognitive dysfunction, autonomic failure, and myoclonus[18]LBs and Lewy neurites; ± glial inclusions; hippocampal CA2 and CA3 lossMid 20s - 30s
A53T, A30P E46K[19][20] Idiopathic PD; early on setparkinsonism and diffuse LBsLBs and LNs; ± tau inclusions; amyloid plaques 30 - 60
PARK2[14] Parkin[21] E3 ubiquitin ligase[22] 200+ possible mutations including:[22]- Inactivating somatic mutations- Frequent intragenic deletionsEarly on set Parkinsonism; slow progression PD variable presence of LBs Juvenile to 40 Recessive
PARK5[14] UCHL1 deubiquitinating enzyme Missense: Ile93Met[23] PD; late on set parkinsonism Unknown; various abnormal protein aggregations 30 - 50 Dominant
PARK6[14] PINK1[24] mitochondrial Ser-Thr Kinase 40+ mutations[24]-Mostly point mutations-Deletions on C-terminus Kinase domainParkinsonism Unknown 30 - 50 Recessive
PARK7[14] DJ-1[49] oxidative stress response? -10 point mutations including C46A, C53A, C106 & WT regions[25]- Large deletion in L166PEarly onset Parkinsonism Unknown 20 - 40 Recessive
PARK8[14] LRRK2 (dardarin)12q12[26] unknown protein kinase G2019S most common[27] late-onset Parkinson's Disease[28] Diffuse LBs; LNs; ± tau inclusions; ± amyloid plaques 40 - 60 Dominant

Environmental factors

Exposure to pesticides, metals, solvents, and other toxicants has been studied as a factor in the development of Parkinson's disease.[29] No definitive causal relationship has yet been established. Recent studies also reveal that individuals that sustain mild head injuries (concussions) also have an increased risk of acquiring the disease.[30][31] As discussed below, exercise and caffeine consumption are known to help decrease the risks of acquisition.

Pesticides

Evidence from epidemiological, animal, and in vitro studies suggests that exposure to pesticides increases the risk for Parkinson's disease.[29] One meta-analysis found a risk ratio of 1.6 for ever being exposed to a pesticide, with herbicides and insecticides showing the most risk.[29][32] Rural living, well-drinking, and farming were also associated with Parkinson's, which may be partly explained by pesticide exposure.[32] Organochlorine pesticides (which include DDT) have received the most attention, with several studies reporting that exposure to such pesticides is associated with a doubling of risk for Parkinson's.[29]

Metals

Lead, which was used in gasoline until 1995 and paint until 1978, is known to damage the nervous system in various ways.[29] A few studies have found that people with high levels of lead in their body had twice the risk of Parkinson's disease.[29] Epidemiological studies on lead, however, have found little evidence for a link with Parkinson's.[29] Iron has been implicated in the etiology of Parkinson's disease, but there is no strong evidence that environmental exposure to it is associated with Parkinson's.[29]

Head injuries

A study in 2018 notes that "Even a mild head injury, commonly called a concussion, makes veterans more likely to get Parkinson's disease later on in life" with this being "the same type of injury suffered by many Americans on the sports field or in a motor vehicle crash each year."[33] An earlier study, published in 2012, suggests that playing in the NFL triples the risk of Alzheimer's and Parkinson's disease.[34]

Exercise

While many environmental factors may exacerbate Parkinson's Disease, exercise is considered to be one of the main protective factors for neurodegenerative disorders including Parkinson disease. The types of exercise interventions that have been studied can be categorized as either aerobic or goal-based.[35] Aerobic exercise includes physical activity that increases the heart rate. Aerobic exercise is beneficial to the overall brain through mechanisms that promote neuroplasticity, or the rewiring of the brain circuitry.[35] Goal-based exercises are often developed with the guidance of a physical therapist to use movement to improve motor task performance and enhance motor learning.[35] While exercise has consistently been shown to be beneficial, the optimal interventional benefit is still being researched.[36]

Caffeine Consumption

Studies have been done with groups of people where individuals (smokers and nonsmokers) with different rates of caffeine consumption were monitored for their susceptibility to PD. The results of these findings indicated that higher coffee/caffeine intake is associated with a significantly lower incidence of PD and that this effect appeared to be independent of smoking.[37]

Environmental-Genetic factors

Polymorphism of CYP2D6 gene and pesticide exposure

The CYP2D6 gene is primarily expressed in the liver and is responsible for the enzyme cytochrome P450 2D6. A study showed that those who had a mutation of this gene and were exposed to pesticides were twice as likely to develop Parkinson's Disease; those that had the mutation and were not exposed to pesticides were not found to be at an increased risk of developing PD; the pesticides only had a "modest effect" for those without the mutation of the gene.[18][38]

References

1. ^{{cite journal|last=Samii|first=A|author2=Nutt, JG |author3=Ransom, BR |title=Parkinson's disease.|journal=Lancet|date=May 29, 2004|volume=363|issue=9423|pages=1783–93|pmid=15172778|doi=10.1016/S0140-6736(04)16305-8}}
2. ^1 2 3 4 5 6 7 8 9 10 {{cite journal|vauthors=Lesage S, Brice A |title=Parkinson's disease: from monogenic forms to genetic susceptibility factors |journal=Hum. Mol. Genet. |volume=18 |issue=R1 |pages=R48–59 |date=April 2009 |pmid=19297401 |doi=10.1093/hmg/ddp012}}
3. ^{{Cite journal|last=Larsen|first=S. B.|last2=Hanss|first2=Z.|last3=Krüger|first3=R.|date=2018-01-25|title=The genetic architecture of mitochondrial dysfunction in Parkinson's disease|journal=Cell and Tissue Research|volume=373|issue=1|pages=21–37|doi=10.1007/s00441-017-2768-8|issn=1432-0878|pmid=29372317|pmc=6015629}}
4. ^{{cite journal |author=Davie CA |title=A review of Parkinson's disease |journal=Br. Med. Bull. |volume=86 |issue= 1|pages=109–27 |year=2008 |pmid=18398010|doi=10.1093/bmb/ldn013 }}
5. ^{{cite journal|last=Kitada|first=T|author2=Asakawa S|author3=Hattori N|author4=Matsumine H|author5=Yamamura Y|author6=Minoshima S|author7=Yokochi M|author8=Mizuno Y|author9=Shimizu N.|title=Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism|journal=Nature|date=April 1998|volume=392|issue=6676|pages=605–608|pmid=9560156|doi=10.1038/33416|bibcode=1998Natur.392..605K}}
6. ^{{cite journal|last=Neumann|first=J|author2=Bras J|author3=Deas E|author4=O'Sullivan SS|author5=Parkkinen L|author6=Lachmann RH|author7=Li A|author8=Holton J|author9=Guerreiro R|author10=Paudel R|author11=Segarane B|author12=Singleton A|author13=Lees A|author14=Hardy J|author15=Houlden H|author16=Revesz T|author17= Wood NW.|title=Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease|journal=Brain|date=March 2009|volume=132|issue=7|pages=1783–94|pmid=19286695|doi=10.1093/brain/awp044|pmc=2702833}}
7. ^1 2 {{cite journal|last=Davie|first=CA|title=A review of Parkinson's disease.|journal=British Medical Bulletin|year=2008|volume=86|pages=109–27|doi=10.1093/bmb/ldn013|pmid=18398010}}
8. ^{{Cite journal|last=Dhungel|first=Nripesh|last2=Eleuteri|first2=Simona|last3=Li|first3=Ling-bo|last4=Kramer|first4=Nicholas J.|last5=Chartron|first5=Justin W.|last6=Spencer|first6=Brian|last7=Kosberg|first7=Kori|last8=Fields|first8=Jerel Adam|last9=Stafa|first9=Klodjan|date=2015-01-07|title=Parkinson's Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein|journal=Neuron|language=English|volume=85|issue=1|pages=76–87|doi=10.1016/j.neuron.2014.11.027|issn=0896-6273|pmc=4289081|pmid=25533483}}
9. ^1 {{cite journal|last=Martin|first=I|date=Sep 2011|title=Recent Advances in the Genetics of Parkinson's Disease.|journal=Annu. Rev. Genom. Hum. Genet.|volume=12|issue=10|pages=301–25|doi=10.1146/annurev-genom-082410-101440|pmc=4120236|pmid=21639795|author2=Dawson, VL|author3=Dawson, TM}}
10. ^{{cite journal|last=Funayama|first=M|date=March 2002|title=A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.|journal=Annals of Neurology|volume=51|issue=3|pages=296–301|doi=10.1002/ana.10113|pmid=11891824|author2=Hasegawa K|author3=Kowa H|author4=Saito M|author5=Tsuji S|author6=Obata F.}}
11. ^1 {{cite journal|last=Chen-Plotkin|first=AS|author2=Martinez-Lage, M |author3=Sleiman, PMA |author4=Hu, W |date=Apr 2011|title=Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration.|journal=Arch. Neurol.|volume=68|issue=4|pages=488–97|pmid=21482928|doi=10.1001/archneurol.2011.53|display-authors=etal |pmc=3160280}}
12. ^{{cite journal |author=IPDGC |title=Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies |journal=Lancet |volume=377 |pages= 641–649|year=2011 |pmid= 21292315 |doi=10.1016/S0140-6736(10)62345-8 |issue=9766 |last2=Nalls |first2=MA |last3=Plagnol |first3=V|last4=Hernandez |first4=DG |last5=Sharma |first5=M |last6=Sheerin |first6=UM |last7=Saad |first7=M |last8=Simón-Sánchez|first8=J |last9=Schulte |first9=C |last10=Lesage |first10=S |last11=Sveinbjörnsdóttir |first11=S |last12=Stefánsson |first12=K |last13=Martinez |first13=M |last14=Hardy |first14=J |last15=Heutink |first15=P |last16=Brice |first16=A |last17=Gasser |first17=T |last18=Singleton |first18=A. B. |last19=Wood |first19=N. W. |pmc=3696507|display-authors=8 }}
13. ^1 2 {{cite journal|last=Sidransy|first=E|last2=Lopez|first2=G|title=The link between the GBA gene and parkinsonism|journal=Lancet Neurol.|volume=11|pages=986–98|date=Nov 2012|pmid=23079555|doi=10.1016/S1474-4422(12)70190-4|issue=11|pmc=4141416}}
14. ^1 2 3 4 5 {{cite journal|last=Wood-Kaczmar|first=A|author2=Gandhi, S |author3=Wood, NW |title=Understanding the molecular causes of Parkinson's disease.|journal=Trends in Molecular Medicine|date=Nov 2006|volume=12|issue=11|pages=521–8|pmid=17027339|doi=10.1016/j.molmed.2006.09.007}}
15. ^{{cite journal|last=Cookson|first=MR|title=The biochemistry of Parkinson's disease.|journal=Annual Review of Biochemistry|year=2005|volume=74|pages=29–52|pmid=15952880|doi=10.1146/annurev.biochem.74.082803.133400}}
16. ^1 {{Cite web|url=https://ghr.nlm.nih.gov/gene/SNCA#location|title=SNCA|last=Reference|first=Genetics Home|website=Genetics Home Reference|access-date=2016-08-16}}
17. ^1 {{Cite web|url=https://ghr.nlm.nih.gov/gene/SNCA|title=SNCA|last=Reference|first=Genetics Home|website=Genetics Home Reference|access-date=2016-08-16}}
18. ^1 {{Cite journal|last=Tsuboi|first=Yoshio|date=2012-09-01|title=Environmental-Genetic Interactions in the Pathogenesis of Parkinson's Disease|journal=Experimental Neurobiology|volume=21|issue=3|pages=123–128|doi=10.5607/en.2012.21.3.123|issn=1226-2560|pmc=3454809|pmid=23055790}}
19. ^{{cite journal|last=Lesage|first=S|author2=Brice, A|title=Parkinson's disease: from monogenic forms to genetic susceptibility factors.|journal=Human Molecular Genetics|date=Apr 15, 2009|volume=18|issue=R1|pages=R48–59|pmid=19297401|doi=10.1093/hmg/ddp012}}
20. ^{{cite journal|last=Teismann|first=P|author2=Schulz, JB|title=Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.|journal=Cell and Tissue Research|date=Oct 2004|volume=318|issue=1|pages=149–61|pmid=15338271|doi=10.1007/s00441-004-0944-0}}
21. ^{{cite journal|last=Thompson|first=SJ|author2=Loftus, LT |author3=Ashley, MD |author4= Meller, R |title=Ubiquitin-proteasome system as a modulator of cell fate.|journal=Current Opinion in Pharmacology|date=Feb 2008|volume=8|issue=1|pages=90–5|pmid=17981502|doi=10.1016/j.coph.2007.09.010|pmc=2265078}}
22. ^1 {{cite journal|last=Kim|first=SY|author2=Seong, MW |author3=Jeon, BS |author4=Kim, SY |author5=Ko, HS |author6=Kim, JY |author7= Park, SS |title=Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.|journal=Clinical Genetics|date=Jul 2012|volume=82|issue=1|pages=77–82|pmid=21534944|doi=10.1111/j.1399-0004.2011.01693.x}}
23. ^{{cite journal|last=Leroy|first=E|author2=Boyer, R |title=The ubiquitin pathway in Parkinson's disease|journal=Nature|date=Oct 1, 1998|volume=395|issue=6701|pages=451–2|pmid=9774100|doi=10.1038/26652|bibcode=1998Natur.395..451L|last3=Auburger|first3=Georg|last4=Leube|first4=Barbara|last5=Ulm|first5=Gudrun|last6=Mezey|first6=Eva|last7=Harta|first7=Gyongyi|last8=Brownstein|first8=Michael J.|last9=Jonnalagada|first9=Sobhanadditya|last10=Chernova|first10=Tanya|last11=Dehejia|first11=Anindya|last12=Lavedan|first12=Christian|last13=Gasser|first13=Thomas|last14=Steinbach|first14=Peter J.|last15=Wilkinson|first15=Keith D.|last16=Polymeropoulos|first16=Mihael H.}}
24. ^1 {{cite journal|last=Hatano|first=Y|author2=Li, Y|author3=Sato, K|author4=Asakawa, S|author5=Yamamura, Y|author6=Tomiyama, H|author7=Yoshino, H|author8=Asahina, M|author9=Kobayashi, S|author10=Hassin-Baer, S|author11=Lu, CS|author12=Ng, AR|author13=Rosales, RL|author14=Shimizu, N|author15=Toda, T|author16=Mizuno, Y|author17=Hattori, N|title=Novel PINK1 mutations in early-onset parkinsonism|journal=Annals of Neurology|date=Sep 2004|volume=56|issue=3|pages=424–7|pmid=15349870|doi=10.1002/ana.20251}}
25. ^1 {{cite journal|last=Bonifati|first=V|author2=Rizzu, P|author3=van Baren, MJ|author4=Schaap, O|author5=Breedveld, GJ|author6=Krieger, E|author7=Dekker, MC|author8=Squitieri, F|author9=Ibanez, P|author10=Joosse, M|author11=van Dongen, JW|author12=Vanacore, N|author13=van Swieten, JC|author14=Brice, A|author15=Meco, G|author16=van Duijn, CM|author17=Oostra, BA|author18=Heutink, P|title=Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism|journal=Science|date=Jan 10, 2003|volume=299|issue=5604|pages=256–9|pmid=12446870|doi=10.1126/science.1077209}}
26. ^{{Cite web|url=https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRRK2&keywords=LRRK2|title=www.genecards.org/cgi-bin/carddisp.pl?gene=LRRK2&keywords=LRRK2|website=www.genecards.org|access-date=2016-08-16}}
27. ^{{cite journal|last=Hernandez|first=D|author2=Paisan Ruiz, C|author3=Crawley, A|author4=Malkani, R|author5=Werner, J|author6=Gwinn-Hardy, K|author7=Dickson, D|author8=Wavrant Devrieze, F|author9=Hardy, J|author10=Singleton, A|title=The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases|journal=Neuroscience Letters|date=Dec 2005|volume=389|issue=3|pages=137–9|pmid=16102903|doi=10.1016/j.neulet.2005.07.044}}
28. ^{{Cite journal|last=Haugarvoll|first=Kristoffer|last2=Wszolek|first2=Zbigniew K.|date=2009-12-01|title=Clinical features of LRRK2 parkinsonism|journal=Parkinsonism & Related Disorders|volume=15 Suppl 3|pages=S205–208|doi=10.1016/S1353-8020(09)70815-6|issn=1873-5126|pmid=20082991}}
29. ^1 2 3 4 5 6 7 {{cite journal |vauthors=Goldman SM |title=Environmental toxins and Parkinson's disease |journal=Annu. Rev. Pharmacol. Toxicol. |volume=54 |issue= |pages=141–64 |year=2014 |pmid=24050700 |doi=10.1146/annurev-pharmtox-011613-135937}}
30. ^{{Cite web | url=https://abcnews.go.com/Health/mild-head-injury-increases-risk-parkinsons-disease-veterans/story?id=54563248 | title=Even a mild head injury increases risk for Parkinson's disease, veterans study shows| date=2018-04-19}}
31. ^https://www.usnews.com/news/articles/2012/09/05/playing-in-nfl-triples-risk-of-alzheimers-parkinsons-diseases/
32. ^1 {{cite journal |vauthors=Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A |title=Meta-analysis of early nonmotor features and risk factors for Parkinson disease |journal=Ann. Neurol. |volume=72 |issue=6 |pages=893–901 |year=2012 |pmid=23071076 |pmc=3556649 |doi=10.1002/ana.23687 |url=}}
33. ^{{Cite web | url=https://abcnews.go.com/Health/mild-head-injury-increases-risk-parkinsons-disease-veterans/story?id=54563248 | title=Even a mild head injury increases risk for Parkinson's disease, veterans study shows| date=2018-04-19}}
34. ^https://www.usnews.com/news/articles/2012/09/05/playing-in-nfl-triples-risk-of-alzheimers-parkinsons-diseases
35. ^1 2 Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson’s disease. The Lancet Neurology. 2013;12(7):716-726. doi:10.1016/S1474-4422(13)70123-6.
36. ^Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson’s disease: A systematic review and meta-analysis. Mov Disord. 2008;23(5):631-640. doi:10.1002/mds.21922.
37. ^Tsuboi, Y. (2012, September). Environmental-Genetic Interactions in the Pathogenesis of Parkinson's Disease. Retrieved November 29, 2017, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454809/
38. ^{{Cite journal|last=Elbaz|first=Alexis|last2=Levecque|first2=Clotilde|last3=Clavel|first3=Jacqueline|last4=Vidal|first4=Jean-Sébastien|last5=Richard|first5=Florence|last6=Amouyel|first6=Philippe|last7=Alpérovitch|first7=Annick|last8=Chartier-Harlin|first8=Marie-Christine|last9=Tzourio|first9=Christophe|date=2004-03-01|title=CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease|journal=Annals of Neurology|language=en|volume=55|issue=3|pages=430–434|doi=10.1002/ana.20051|pmid=14991823|issn=1531-8249}}

2 : Etiology|Parkinson's disease
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/9/24 15:19:00